ixekizumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen AUST R: 253893Active ingredients:
ixekizumab
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
0293254755
|
Deletion from market:
10 Feb 2026
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
The sponsor has transitioned to the new formulation of TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen (ARTG 414414).
|